Skip to content

Ketamine: all studies

Page 92 of 448: studies 911 to 920 of 4,475, newest first. Back to the ketamine overview

Research

Response to Ketamine Therapy in Anxious and Non-Anxious Major Depressive Disorder: A Meta-Analysis of Clinical Trials

European Psychiatry April 1, 2025 Ilídio Oliveira, A. L. Stephany, M. L. Geremias et al.

Introduction Anxious depression (AxD) as an independent diagnostic has been controversial, with many suggesting it as a transient state and others highlighting evidence of a worse outcome, severity, and increased suicide risk. The International Classification of Diseases (ICD-11) lists a related concept under 6A73, Mixed depressive and anxiety disorder. Previous literature on ketamine’s...

Detection of dissociative states in patients during the administration of Es-ketamine by monitoring with the Dissociative Experience Scale II (DES II) - Part I

European Psychiatry April 1, 2025 Cristina Serritella, Federica Ferraiuolo, Mark Piccirillo et al.

Introduction The effectiveness of Es-ketamine therapy in the treatment of psycho-pathological symptoms is the subject of growing interest in the scientific community. Through the use of validated psychometric instruments, this study aims to delineate more precisely the mechanisms of action and clinical potential of this therapy, contributing to the advancement of knowledge in psychiatry....

DOI: 10.1192/j.eurpsy.2025.414 (opens in new tab) Full text (opens in new tab) Dissociative disorders Dissociation chemistry Dissociative experiences scale Clinical global impression +2

Ketamine for Critically Ill Patients with Severe Acute Brain Injury: A Systematic Review with Meta-analysis and Trial Sequential Analysis of Randomized Clinical Trials.

Neurocritical care April 1, 2025 Trine Hjorslev Andreasen, Frederik Andreas Madsen, Marija Barbateskovic et al. 8 citations

Patients with severe acute brain injury have a high risk of a poor clinical outcome due to primary and secondary brain injury. Ketamine reportedly inhibits cortical spreading depolarization, an electrophysiological phenomenon that has been associated with secondary brain injury, making ketamine potentially attractive for patients with severe acute brain injury. The aim of this systematic review...

DOI: 10.1007/s12028-024-02075-2 (opens in new tab) Full text (opens in new tab) Ketamine Brain injuries Cortical spreading depression Intensive care units +3

Functional connectivity subtypes during a positive mood induction: Predicting clinical response in a randomized controlled trial of ketamine for treatment-resistant depression.

Journal of Psychopathology and Clinical Science April 1, 2025 Shabnam Hossein, Mary L Woody, Benjamin Panny et al. 3 citations

Ketamine has shown promise in rapidly improving symptoms of depression and most notably treatment-resistant depression (TRD). However, given the heterogeneity of TRD, biobehavioral markers of treatment response are necessary for the personalized prescription of intravenous ketamine. Heterogeneity in depression can be manifested in discrete patterns of functional connectivity (FC) in default...

DOI: 10.1037/abn0000951 (opens in new tab) Full text (opens in new tab) Depression treatment Brain connectivity Mood patterns Personalized medicine +1

The Use of Prophylactic Ketamine to Mitigate Postoperative Depressive Symptoms: A Systematic Review.

Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses April 1, 2025 Eleanor Yip, Desiree Fleck 1 citation

Depression is predicted to be the leading burden of disease worldwide by 2030 with a prevalence of 10% to 60% in the surgical population. Depressive symptoms in the perioperative population are associated with a myriad of grave complications, including higher morbidity and mortality. This systematic review aims to determine whether a single dose of intravenous ketamine can be used...

DOI: 10.1016/j.jopan.2024.05.026 (opens in new tab) Full text (opens in new tab) Surgical complications Systematic review Ketamine therapy Surgical depression +3

Hepatic adverse events associated with ketamine and esketamine: A population-based disproportionality analysis.

Journal of Affective Disorders April 1, 2025 Angela T H Kwan, Moiz Lakhani, Kayla M Teopiz et al. 11 citations

To determine whether there is disproportionate reporting of hepatobiliary disorders in the United States (US) FDA Adverse Event Reporting System (FAERS) for individuals prescribed ketamine or esketamine. We identified Medical Dictionary for Regulatory Activities (MedDRA) terms in the FAERS related to hepatobiliary disorders. Formulations of ketamine and esketamine were evaluated for the...

DOI: 10.1016/j.jad.2025.01.054 (opens in new tab) Full text (opens in new tab) Esketamine Drug-induced liver injury Hepatobiliary disorders Hepatotoxicity +9

Ketamine Treatment for Pediatric Refractory Obsessive: Five Open Label Cases.

Journal of Child and Adolescent Psychopharmacology April 1, 2025 Hannah S Ishimuro, Paula K Yanes-Lukin, Pablo H Goldberg et al. 6 citations

Importance: Selective serotonin reuptake inhibitors (SSRIs) and cognitive behavioral therapy are the first-line treatments for pediatric obsessive-compulsive disorder (OCD) populations. Due to their limited effectiveness, additional treatment options are needed. A new potential pharmacological medication treatment avenue for OCD is intravenous (IV) ketamine. Objective: This study aimed to...

DOI: 10.1089/cap.2024.0127 (opens in new tab) Full text (opens in new tab) Obsessive-compulsive disorder Ketamine therapy Adolescent mental health OCD Treatment +2

Oral ketamine for rapid reduction of suicidal ideation in major depressive disorder: A midazolam-controlled randomized clinical trial.

Asian Journal of Psychiatry April 1, 2025 Asif Seraj, Mohammed Reyazuddin, R K Gaur et al. 11 citations

The simplest, most convenient, and least expensive way to treat depressed and suicidal patients with ketamine is to administer racemic ketamine by the oral route. We describe the first active-controlled randomized clinical trial of oral racemic ketamine for suicidal ideation associated with depression. Adult patients with major depressive disorder and expressed suicidal ideation were randomized...

Lithium attenuates ketamine-induced long-term neurotoxicity through DISC1-mediated GSK-3β/β-catenin and ERK/CREB pathways.

Toxicology Letters April 1, 2025 Ting-Ting Yang, Zi-Wen Guo, Fang Zhang et al. 2 citations

Ketamine, an antagonist of N-methyl-D-aspartate receptor, is extensively employed in pediatric anesthesia. Multiple studies have shown that repeated ketamine exposure induces neuroapoptosis, synaptic changes and cognitive deficits during neurodevelopment. Therefore, it is essential to elucidate the mechanisms of ketamine-induced neurotoxicity and develop therapies to mitigate its harmful...

DOI: 10.1016/j.toxlet.2025.02.012 (opens in new tab) Full text (opens in new tab) Disc1 Erk/creb pathway Gsk-3β/β-catenin pathway Neurotoxicity +5

Ketamine: An emerging agent in the management of neuropsychiatric disorders.

Asian Journal of Psychiatry April 1, 2025 Nathan Menke, Elizabeth Hoffman, Kelsey Gaylor et al. 4 citations

Ketamine's unique pharmacological profile, safety, modulation of multiple neurotransmitter systems, and ability to produce neuroplastic changes make it a subject of study with implications for a wide range of neuropsychiatric disorders beyond its traditional use as an anesthetic agent. This article aims to provide an overview of the pharmacology of ketamine and briefly discuss its emerging use...

DOI: 10.1016/j.ajp.2024.104351 (opens in new tab) Full text (opens in new tab) Cannabis Addiction treatment Substance dependence Mental health interventions +10